198 related articles for article (PubMed ID: 9392480)
1. Sensitization to insulin induced by beta,beta'-methyl-substituted hexadecanedioic acid (MEDICA 16) in obese Zucker rats in vivo.
Mayorek N; Kalderon B; Itach E; Bar-Tana J
Diabetes; 1997 Dec; 46(12):1958-64. PubMed ID: 9392480
[TBL] [Abstract][Full Text] [Related]
2. Adipose tissue sensitization to insulin induced by troglitazone and MEDICA 16 in obese Zucker rats in vivo.
Kalderon B; Mayorek N; Ben-Yaacov L; Bar-Tana J
Am J Physiol Endocrinol Metab; 2003 Apr; 284(4):E795-803. PubMed ID: 12488241
[TBL] [Abstract][Full Text] [Related]
3. Thiazolidinediones increase plasma-adipose tissue FFA exchange capacity and enhance insulin-mediated control of systemic FFA availability.
Oakes ND; Thalén PG; Jacinto SM; Ljung B
Diabetes; 2001 May; 50(5):1158-65. PubMed ID: 11334421
[TBL] [Abstract][Full Text] [Related]
4. Hypolipidemic, antiobesity, and hypoglycemic-hypoinsulinemic effects of beta,beta'-methyl-substituted hexadecanedioic acid in sand rats.
Tzur R; Rose-Kahn G; Adler JH; Bar-Tana J
Diabetes; 1988 Dec; 37(12):1618-24. PubMed ID: 3056760
[TBL] [Abstract][Full Text] [Related]
5. Adipose reduction by beta,beta'-tetramethyl-substituted hexadecanedioic acid (MEDICA 16).
Tzur R; Smith E; Bar-Tana J
Int J Obes; 1989; 13(3):313-26. PubMed ID: 2670791
[TBL] [Abstract][Full Text] [Related]
6. Fatty acid cycling in the fasting rat.
Kalderon B; Mayorek N; Berry E; Zevit N; Bar-Tana J
Am J Physiol Endocrinol Metab; 2000 Jul; 279(1):E221-7. PubMed ID: 10893343
[TBL] [Abstract][Full Text] [Related]
7. θ-Defensin RTD-1 improves insulin action and normalizes plasma glucose and FFA levels in diet-induced obese rats.
Oh YT; Tran D; Buchanan TA; Selsted ME; Youn JH
Am J Physiol Endocrinol Metab; 2015 Jul; 309(2):E154-60. PubMed ID: 25991648
[TBL] [Abstract][Full Text] [Related]
8. Topiramate is an insulin-sensitizing compound in vivo with direct effects on adipocytes in female ZDF rats.
Wilkes JJ; Nelson E; Osborne M; Demarest KT; Olefsky JM
Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E617-24. PubMed ID: 15536205
[TBL] [Abstract][Full Text] [Related]
9. Lowering plasma free fatty acids with Acipimox mimics the antidiabetic effects of the beta 3-adrenergic agonist CL-316243 in obese Zucker diabetic fatty rats.
Blachère JC; Pérusse F; Bukowiecki LJ
Metabolism; 2001 Aug; 50(8):945-51. PubMed ID: 11474483
[TBL] [Abstract][Full Text] [Related]
10. Development of insulin resistance in the JCR:LA-cp rat: role of triacylglycerols and effects of MEDICA 16.
Russell JC; Shillabeer G; Bar-Tana J; Lau DC; Richardson M; Wenzel LM; Graham SE; Dolphin PJ
Diabetes; 1998 May; 47(5):770-8. PubMed ID: 9588449
[TBL] [Abstract][Full Text] [Related]
11. Development of obesity in Zucker rats. Early insulin resistance in muscles but normal sensitivity in white adipose tissue.
Pénicaud L; Ferré P; Terretaz J; Kinebanyan MF; Leturque A; Doré E; Girard J; Jeanrenaud B; Picon L
Diabetes; 1987 May; 36(5):626-31. PubMed ID: 3552794
[TBL] [Abstract][Full Text] [Related]
12. The hypochylomicronemic effect of beta,beta'-methyl-substituted hexadecanedioic acid (MEDICA 16) is mediated by a decrease in apolipoprotein C-III.
Frenkel B; Mayorek N; Hertz R; Bar-Tana J
J Biol Chem; 1988 Jun; 263(17):8491-7. PubMed ID: 3372539
[TBL] [Abstract][Full Text] [Related]
13. Hypolipidemic effect of beta, beta'-tetramethyl hexadecanedioic acid (MEDICA 16) in hyperlipidemic JCR:LA-corpulent rats.
Russell JC; Dolphin PJ; Hameed M; Stewart B; Koeslag DG; Rose-Kahn G; Bar-Tana J
Arterioscler Thromb; 1991; 11(3):602-9. PubMed ID: 2029500
[TBL] [Abstract][Full Text] [Related]
14. A new antidiabetic agent, BRL 49653, reduces lipid availability and improves insulin action and glucoregulation in the rat.
Oakes ND; Kennedy CJ; Jenkins AB; Laybutt DR; Chisholm DJ; Kraegen EW
Diabetes; 1994 Oct; 43(10):1203-10. PubMed ID: 7926289
[TBL] [Abstract][Full Text] [Related]
15. Effect of 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside infusion on in vivo glucose and lipid metabolism in lean and obese Zucker rats.
Bergeron R; Previs SF; Cline GW; Perret P; Russell RR; Young LH; Shulman GI
Diabetes; 2001 May; 50(5):1076-82. PubMed ID: 11334411
[TBL] [Abstract][Full Text] [Related]
16. Quercetin ameliorates metabolic syndrome and improves the inflammatory status in obese Zucker rats.
Rivera L; Morón R; Sánchez M; Zarzuelo A; Galisteo M
Obesity (Silver Spring); 2008 Sep; 16(9):2081-7. PubMed ID: 18551111
[TBL] [Abstract][Full Text] [Related]
17. Characterization of new oral antidiabetic agent CS-045. Studies in KK and ob/ob mice and Zucker fatty rats.
Fujiwara T; Yoshioka S; Yoshioka T; Ushiyama I; Horikoshi H
Diabetes; 1988 Nov; 37(11):1549-58. PubMed ID: 3053303
[TBL] [Abstract][Full Text] [Related]
18. A low dietary intake of cod protein is sufficient to increase growth, improve serum and tissue fatty acid compositions, and lower serum postprandial glucose and fasting non-esterified fatty acid concentrations in obese Zucker fa/fa rats.
Drotningsvik A; Mjøs SA; Høgøy I; Remman T; Gudbrandsen OA
Eur J Nutr; 2015 Oct; 54(7):1151-60. PubMed ID: 25380663
[TBL] [Abstract][Full Text] [Related]
19. Surgical removal of visceral fat decreases plasma free fatty acid and increases insulin sensitivity on liver and peripheral tissue in monosodium glutamate (MSG)-obese rats.
Kim YW; Kim JY; Lee SK
J Korean Med Sci; 1999 Oct; 14(5):539-45. PubMed ID: 10576150
[TBL] [Abstract][Full Text] [Related]
20. Improved metabolic status and insulin sensitivity in obese fatty (fa/fa) Zucker rats and Zucker Diabetic Fatty (ZDF) rats treated with the thiazolidinedione, MCC-555.
Upton R; Widdowson PS; Ishii S; Tanaka H; Williams G
Br J Pharmacol; 1998 Dec; 125(8):1708-14. PubMed ID: 9886762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
